Rafael Holdings, Inc. (RFL): EBITDA
-$28.87M
Year ended 2025-07-31
-$36.24M
Trailing 12 months to 2026-04-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | -$28.87M | n/m | 2025-10-29, From 2024-08-01 |
| 2024-07-31 | -$102.40M | n/m | 2025-10-29, From 2023-08-01 |
| 2023-07-31 | -$14.96M | n/m | 2024-12-20, From 2022-08-01 |
| 2022-07-31 | -$60.41M | n/m | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | -$28.13M | n/c | 2022-10-31, From 2020-08-01 |
| 2020-07-31 | -$6.60M | n/m | 2021-10-18, From 2019-08-01 |
| 2019-07-31 | -$4.92M | n/m | 2020-10-29, From 2018-08-01 |
| 2018-07-31 | -$2.14M | n/m | 2019-10-04, From 2017-08-01 |
| 2017-07-31 | $1.89M | -33.3% | 2018-10-15, From 2016-08-01 |
| 2016-07-31 | $2.83M | n/a | 2018-10-15, From 2015-08-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$28.87M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$32.97M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$47.81M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$7.72M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$11.92M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$17.84M | n/m |
| Hyperion Defi, Inc. (HYPD) | 2024-12-31 | -$47.61M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$7.05M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$15.79M | n/m |
Compare RFL, RLYB, STTK, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗